Wednesday, August 2, 2017
Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand its use of the Medidata Clinical Cloud to further digitize patient reporting for its oncology research studies.
Adimab, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas. This technology transfer expands an ongoing collaboration between the two companies that was initiated in 2010, which has yielded several undisclosed therapeutic candidates for Lilly.
Science Exchange is the first and only R&D outsourcing platform to receive EU-U.S. Privacy Shield Framework certification from the U.S. Department of Commerce. This certification demonstrates the company’s commitment to the protection and privacy of sensitive data shared by its customers and scientific service providers on the Science Exchange platform.
TrialScope, a global leader in patient-centric clinical trial transparency and compliance solutions, announced that the Trial Results Summaries Portal now supports trial summaries in English and seven additional languages: Chinese, French, German, Japanese, Polish, Russian and Spanish.
Mapi, a developer of Linguistic Validation and most trusted provider of Clinical Outcome Assessments, is collaborating with YPrime, a clinical research technology provider, to streamline the deployment of validated Assessments migrated onto YPrime’s eCOA platform.
eClinicalHealth introduces Clinpal EDC, the first application for data capture on a single cloud platform that provides an intuitive experience for patients and sites as well as all sponsor and CRO stakeholders.
Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced that after an exhaustive 18 month selection process that encompassed all of the leading site payments technologies, Worldwide Clinical Trials has selected Medidata Payments Cloud to streamline accurate, timely payments on behalf of their clinical trial sponsors.
The EQT VII fund has agreed to acquire Certara, a provider of technology-driven decision support solutions for drug development, for an enterprise value of $850 million. The company is being acquired from Arsenal Capital Partners. As part of the transaction, Arsenal Capital Partners will retain a minority ownership stake in Certara, with the Company’s current management team, led by Edmundo Muniz, M.D., Ph.D., continuing to lead the organization, building on a multi-year track record of both organic growth and strategic acquisitions.
CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, has collaborated with a research group led by Professor Ludwig Kappos at the University Hospital Basel (UHB) to develop an electronic implementation of the Neurostatus-Expanded Disability Status Scale (Neurostatus-EDSS), an established assessment and documentation tool for multiple sclerosis (MS) clinical trials.